News

Opinion
Zacks Investment Research on MSN2dOpinion
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...
If you are buying name brands like Advil, Tylenol, Bayer Aspirin, Prilosec, Zyrtec, Claritin and Sudafed, you are wasting ...
Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new manufacturing sites within the U.S., it's still heavily reliant on its ...
Patent settlements accelerate the entry of generics and biosimilars, saving the health care system $422.9 billion and ...